James Cummings
2021
In 2021, James Cummings earned a total compensation of $2.4M as Chief Medical Officer at Biota Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $36,092 |
|---|---|
| Option Awards | $2,228,040 |
| Salary | $112,154 |
| Other | $3,707 |
| Total | $2,379,993 |
Cummings received $2.2M in option awards, accounting for 94% of the total pay in 2021.
Cummings also received $36.1K in non-equity incentive plan, $112.2K in salary and $3.7K in other compensation.
Rankings
In 2021, James Cummings' compensation ranked 5,350th out of 12,405 executives tracked by ExecPay. In other words, Cummings earned more than 56.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,350 out of 12,405 | 57th |
Division Manufacturing | 2,249 out of 5,494 | 59th |
Major group Chemicals And Allied Products | 979 out of 2,369 | 59th |
Industry group Drugs | 871 out of 2,090 | 58th |
Industry Biological Products, Except Diagnostic Substances | 215 out of 452 | 52nd |
Source: SEC filing on April 28, 2023.
Cummings' colleagues
We found two more compensation records of executives who worked with James Cummings at Biota Pharmaceuticals in 2021.